NLRP3 and hypertensive disorder: NLRP3−/− and WT mice were treated with angiotensin‐II (500 or 1500 ng/kg body weight each day from GD10‐17) to mimic the hypertension seen in PE. The vehicle (control) group received a PBS infusion. Foetal weights were measured at GD17.